Free Trial

Avenue Therapeutics (ATXI) Stock Chart & Stock Price History

Avenue Therapeutics logo
$0.33 -0.03 (-8.33%)
As of 03/27/2025 03:11 PM Eastern

Avenue Therapeutics Stock Price Performance

5 Day
Performance
-8.84%
1 Month
Performance
-70.00%
3 Month
Performance
-82.99%
6 Month
Performance
-86.85%
Year-To-Date
Performance
-83.50%
1 Year
Performance
-97.02%
Receive ATXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATXI Stock Chart for Friday, March, 28, 2025

Remove Ads

Avenue Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
03/27/2025$0.36$0.33
-8.33%
$0.37$0.3327,908 shs$678,000.00
03/26/2025$0.36$0.36
-0.83%
$0.37$0.3613,491 shs$739,000.00
03/25/2025$0.36$0.36
+0.83%
$0.37$0.3525,427 shs$746,000.00
03/24/2025$0.36$0.36
-0.55%
$0.37$0.3617,819 shs$739,000.00
03/21/2025$0.36$0.36
+1.97%
$0.38$0.3595,944 shs$744,000.00
03/20/2025$0.38$0.36
-5.33%
$0.38$0.3592,816 shs$729,000.00
03/19/2025$0.42$0.38
-10.71%
$0.42$0.35173,843 shs$770,000.00
03/18/2025$0.89$0.42
-52.70%
$0.55$0.391.11 million shs$863,000.00
03/17/2025$0.85$0.89
+4.72%
$0.95$0.7966,809 shs$1.82 million
03/14/2025$0.77$0.85
+9.70%
$0.85$0.7283,284 shs$1.74 million
03/13/2025$0.95$0.77
-18.24%
$0.97$0.77173,734 shs$1.59 million
03/12/2025$0.97$0.95
-2.53%
$1.00$0.9320,614 shs$1.94 million
03/11/2025$1.03$0.97
-5.78%
$1.07$0.96102,987 shs$1.99 million
03/10/2025$0.98$1.03
+5.05%
$1.03$0.9831,254 shs$2.12 million
03/07/2025$1.00$0.98
-2.00%
$1.00$0.9638,074 shs$2.01 million
03/06/2025$1.00$1.00$1.00$0.9344,426 shs$2.05 million
03/05/2025$1.00$1.00$1.00$0.9613,128 shs$2.05 million
03/04/2025$1.01$1.00
-0.87%
$1.02$1.0031,233 shs$2.05 million
03/03/2025$1.10$1.01
-8.29%
$1.14$0.99146,843 shs$2.07 million
02/28/2025$1.25$1.10
-12.00%
$1.26$1.05193,012 shs$2.26 million
02/27/2025$1.25$1.25$1.34$1.2560,989 shs$2.56 million

This page (NASDAQ:ATXI) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners